Four genes with disease-related mutations were determined to be significant: SLC39A7, GPR19, ZNF717, and TP53 by using the Cancer-Related Analysis of Variants Toolkit (CRAVAT) for genomic variant interpretation. Here, ZNF717 is linked to cancer.